Berlin: Bayer has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ...

The company's application included a submitted dose of 0.04 millimole gadolinium per kilogram of body weight. If approved, gadoquatrane would become the lowest dose macrocyclic gadolinium-based ...

The DEA Museum explores Bayer's early 20th-century marketing of heroin, originally promoted as a "less addictive" morphine alternative and cough suppressant. Initially hailed as a medical ...

The first-ever synthetic drug went on to become one of the world’s most successful medicines. On Aspirin’s 125th birthday its maker, Bayer, is in no mood for schnapps. In the run-up to the ...